Revenue: The sum of all revenue fields included for a company's operating activities.
Cytek Biosciences, Inc. (CTKB) had Revenue of $52.29M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$52.29M |
$-5.48M |
|
$24.74M |
|
$27.55M |
|
$61.48M |
|
$-9.19M |
|
$1.42M |
|
$-7.77M |
|
$-7.77M |
|
$-5.48M |
|
$-5.48M |
|
$-5.48M |
|
$-5.48M |
|
$-9.19M |
|
$-6.13M |
|
127.55M |
|
127.55M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$388.49M |
|
$18.05M |
|
$106.43M |
|
$494.92M |
|
$75.21M |
|
$0.66M |
|
$41.14M |
|
$116.35M |
|
$378.57M |
|
$344.20M |
|
$378.57M |
|
127.86M |
|
| Cash Flow Statement Financials | |
$-3.92M |
|
$11.96M |
|
$-12.21M |
|
$98.75M |
|
$93.28M |
|
$-5.46M |
|
$19.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
52.69% |
|
-17.58% |
|
-17.58% |
|
-- |
|
-14.86% |
|
-10.48% |
|
$-6.94M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.48 |
|
0.92 |
|
97.47 |
|
-1.45% |
|
-1.59% |
|
-1.11% |
|
-1.44% |
|
$2.96 |
|
$-0.05 |
|
$-0.03 |
|